Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03960840
Title CD19-specific CAR-T Cells in CLL/SLL and DLBCL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

chronic lymphocytic leukemia

diffuse large B-cell lymphoma

Therapies

Ibrutinib + YTB323

YTB323

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | AUT


No variant requirements are available.